Skip to main content
logo
Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,370.00
+460.00 (7.78%)
At close: Aug 24, 2026

KOSDAQ:318160 Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
9,2508,7214,379-1,8572,8903,131
Depreciation & Amortization
2,7502,4341,9061,8031,8611,539
Loss (Gain) From Sale of Assets
-182.48-181.58-12.55218.1519.1763.68
Asset Writedown & Restructuring Costs
---372.86-308.07
Loss (Gain) From Sale of Investments
-5.54-6.81-5-10.2-1,500
Stock-Based Compensation
-----141.91
Provision & Write-off of Bad Debts
334.59409.38-37.26326.3687.8417.06
Other Operating Activities
232.39-186.75-1,4873,527-748.18842.36
Change in Accounts Receivable
-3,464-5,799339.63-1,5261,1361,140
Change in Inventory
-8,013-7,5234,384344.4-2,516-3,192
Change in Accounts Payable
915.431,6311,586202.36-1,5903.93
Change in Other Net Operating Assets
1,2301,988-1,782-1,641-701.91,719
Operating Cash Flow
3,0481,4879,2711,759437.87,614
Operating Cash Flow Growth
-57.04%-83.96%426.97%301.84%-94.25%104.51%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-5,943-6,638-2,024-627.84-360.31-3,725
Sale of Property, Plant & Equipment
1,2411,240116.5826.7432.571.05
Cash Acquisitions
---11,488--
Divestitures
130.05163.05---202
Sale (Purchase) of Intangibles
-252.67-170.75-1.99-504.87-14.63-124.48
Investment in Securities
8,7089,446-2,159-7,4025,033-1,072
Other Investing Activities
-569.93-169.32-567.52-351-671.19112.98
Investing Cash Flow
4,2413,801-4,6432,6304,020-4,535

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-3,2593,6751,3875,3424,535
Long-Term Debt Issued
-9,500----
Total Debt Issued
12,66712,7593,6751,3875,3424,535
Short-Term Debt Repaid
--3,133-6,332--5,008-
Long-Term Debt Repaid
--255-165.97-6,182-14,234-217.48
Total Debt Repaid
-3,870-3,388-6,498-6,182-19,242-217.48
Net Debt Issued (Repaid)
8,7979,372-2,823-4,795-13,9004,317
Issuance of Common Stock
364.96364.96----
Repurchase of Common Stock
-1,093-2,197-2,796-37.25--
Other Financing Activities
7.37.3-5-5-
Financing Cash Flow
8,0777,547-5,623-4,832-13,8954,317

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
64.05-16.7142.60.583.59280.38
Net Cash Flow
15,43012,818-953.01-442.28-9,4347,676

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2,895-5,1517,2471,13177.493,889
Free Cash Flow Growth
--540.50%1360.05%-98.01%-
Free Cash Flow Margin
-5.21%-10.09%25.50%4.14%0.28%11.06%
Free Cash Flow Per Share
-346.29-627.58812.26133.9111.07492.62
Levered Free Cash Flow
-8,069-10,9975,6302,010-1,0152,592
Unlevered Free Cash Flow
-7,726-10,7985,8872,315-730.292,975

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-180.07920.98913.78494.66315.16
Cash Income Tax Paid
650.09745.9791809.632,074428.79
Change in Working Capital
-9,332-9,7034,528-2,621-3,672-329.76